Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

How has the anti-hypertensive drugs market size evolved in recent years?

In the last few years, the market size for anti-hypertensive drugs has shown consistent growth. Forecasts predict it will increase from $36.66 billion in 2024 to $37.5 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 2.3%. The growth observed in the historical phase is a result of various influences including environmental factors, lifestyle changes, previously observed market competition, treatment preferences based on past trends, economic scenario, and preceding global health trends.

What are the predictions for the anti-hypertensive drugs market size in the coming years?

We can anticipate a swift expansion for the rubber gloves sector in the upcoming years, with its market value skyrocketing to $58.26 billion by 2029. This growth signifies a compound annual growth rate (CAGR) of 17.6%. The projected growth within this period can be credited to the escalating standards of food safety, the broadening scope of the healthcare field, an amplified emphasis on infection control and occupational safety measures, and technological advancements in the realm of material science. Some of the major trends forecasted for this period are the broadened utilization of rubber gloves beyond just the healthcare industry, the implementation of sustainability measures in glove manufacturing, specialized customization for particular applications, the forming of strategic alliances and collaborations, as well as stricter regulatory compliance and quality control protocols.

Get your anti-hypertensive drugs market report here!

https://www.thebusinessresearchcompany.com/report/anti-hypertensive-drugs-global-market-report

What key factors are fueling the growth of the anti-hypertensive drugs market?

The expansion of the anti-hypertensive drug market is significantly propelled by sedentary lifestyles. Factors such as the intake of unhealthy fast food, an absence of adequate and balanced nutrition, along with insufficient sleep due to inconsistent work schedules, have all contributed to the surge in hypertension. Hypertension serves as the root cause for roughly 45% of heart disease-related deaths and 51% of deaths linked to strokes. When diagnosed with hypertension, patients must rely on these drugs to manage the condition based on the intensity of the situation. For example, as per the National Health Service, a government body based in England, in May 2023, there’s an observed increase in total hypertension prevalence correlated with age, commencing at 9% in individuals aged between 16 to 44, and escalating to 60% in those who are 65 and above. This establishes a persistent demand for the product and serves as a significant driver for the enhancement of the market.

How is the global anti-hypertensive drugs market divided into key segments?

The anti-hypertensive drugs market covered in this report is segmented –

1) By Therapeutics: Diuretics, Angiotensin Receptor Blockers (ARBs), Angiotensin Converting Enzyme (ACE) Inhibitors, Beta Blockers, Alpha Blockers, Calcium Channel Blockers, Renin Inhibitors, Vasodilators

2) By Disease Source: Primary Hypertension, Secondary Hypertension

3) By End Users: Hospitals, Clinics, Homecare

Subsegments:

1) By Diuretics: Thiazide Diuretics, Loop Diuretics, Potassium-Sparing Diuretics

2) By Angiotensin Receptor Blockers (ARBs): Losartan, Valsartan, Irbesartan, Candesartan

3) By Angiotensin Converting Enzyme (ACE) Inhibitors: Enalapril, Lisinopril, Ramipril, Benazepril

4) By Beta Blockers: Metoprolol, Atenolol, Carvedilol, Bisoprolol

5) By Alpha Blockers: Doxazosin, Prazosin, Terazosin

6) By Calcium Channel Blockers: Amlodipine, Diltiazem, Verapamil, Nifedipine

7) By Renin Inhibitors: Aliskiren

8) By Vasodilators: Hydralazine, Minoxidil

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2410&type=smp

Who are the key firms paving the way for growth in the anti-hypertensive drugs market?

Major companies operating in the anti-hypertensive drugs market include Pfizer Inc., Johnson & Johnson Ltd., F. Hoffmann-La Roche Ltd, Merck & Co. Inc., AbbiVe Inc., Bayer AG, Novartis AG, Sanofi SA, Astra Zeneca plc, Abbott Laboratories, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, C.H. Boehringer Sohn AG & Ko. KG, Teva Pharmaceutical Industries Ltd., Mylan N.V., Daiichi Sankyo Company Limited, Fresenius Kabi AG, Sun Pharmaceuticals LLC, Cipla Limited, Dr. Reddy’s Laboratories, Hikma Pharmaceuticals PLC, Lupin Limited, Torrent Pharmaceuticals Ltd, Noden Pharma DAC, Actelion Pharmaceuticals Ltd.

Which trends are expected to transform the anti-hypertensive drugs market?

In an effort to secure a competitive advantage in the anti-hypertensive drugs market, leading companies are focusing on the introduction of innovative products. These include Metoprolol Succinate Extended-Release Tablets, used to treat patients with hypertension. Granules India Limited, a pharmaceutical manufacturer based in India, received approval from the US Food and Drug Administration (FDA) to launch these tablets in June 2023. The tablets come in varied strengths – 25mg, 50mg, 100mg, and 200mg, and contain beta-blockers to decrease heart rate, lessen the strain on the heart and, consequently, reduce blood pressure. These features make Metoprolol Succinate Extended-Release Tablets a potent tool in the battle against hypertension.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2410

What regions are contributing significantly to the growth of the anti-hypertensive drugs market?

North America was the largest region in the anti-hypertensive drugs market in 2024. The Middle East is expected to be the largest growing region in the global anti-hypertensive drugs market during the forecast period. The regions covered in the anti-hypertensive drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Atmospheric Water Generator Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/atmospheric-water-generator-global-market-report

Refrigerants Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/refrigerants-global-market-report

Vacuum Insulation Panel Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/vacuum-insulation-panel-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: